Ann: Annual Report to shareholders, page-20

further to this my opinion is that ihp is close to commercialisation.

if it wasn't then management (also the purchaser) would be pointing out all the future cost that are associated with this interest.

as it is the company hasn't provided a status update on ihp since they stated in April that they were looking for partners for a commercial plant.

the lack of information given to shareholders noting sh are to vote on the sale of the novaphos asset, to me is a firm indication that ihp is commercial.

management lack of transparency or any ethics on this is a total farce.